Company / PP&E (Net)
Upstream Bio, Inc. PP&E (Net) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$559.0K
FY2025
5-year range
$159.0K / $582.0K
FY2023-FY2025
Trend
-4.0%
vs FY2024
Sector context
#168 of 193
Health Care
What the data says
Upstream Bio, Inc.'s pp&e (net) of $559,000 is lower than 87% of companies in the Health Care sector (FY2025). Improved from $159,000 to $559,000 over the past 2 years.
Based on SEC 10-K filings.
$559,000 in FY2025.
Improved from $159,000 to $559,000 over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 193This company $559.0K Sector average $777.6M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, pp&e (net) decreased 4.0% year-over-year.
- Ranks #168 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $559.0K | -4.0% |
| FY2024 | $582.0K | +266.0% |
| FY2023 | $159.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026